Evaluate the Effectiveness of Crosslinked HA on the Adhesion Preventing After Trigger Finger Release Surgery
A Prospective, Double-Centre, Randomized, Evaluator/Subject-blinded, Control Clinical Study: to Evaluate the Effectiveness of the Use of a Novel Crosslinking Hyaluronan Hydrogel on the Prevention of the Adhesion Occurrence After Trigger Finger Release Surgery
Sponsor: SciVision Biotech Inc.
Terminated
poor enrollment
This NA trial investigates Hyaluronic Acid and Trigger Finger and is currently terminated or withdrawn. SciVision Biotech Inc. leads this study, which shows 7 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jun 2023 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jun 2022 — Jun 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Apr 2022 — Jun 2022 [monthly]
Not Yet Recruiting NA
-
Nov 2021 — Apr 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- SciVision Biotech Inc.
For direct contact, visit the study record on ClinicalTrials.gov .